ジスチグミン臭化物錠適正使用プロトコール導入効果

DOI Web Site 被引用文献1件

書誌事項

タイトル別名
  • The Introduction Effect of the Protocol for the Appropriate Use of Distigmine Bromide Tablets
  • ジスチグミン臭化物錠適正使用プロトコール導入効果 : 薬学的介入に対する薬剤師と患者の意識調査
  • ジスチグミン シュウカブツジョウ テキセイ シヨウ プロトコール ドウニュウ コウカ : ヤクガクテキ カイニュウ ニ タイスル ヤクザイシ ト カンジャ ノ イシキ チョウサ
  • —薬学的介入に対する薬剤師と患者の意識調査—
  • – Survey of Pharmacists and Patients to Pharmaceutical Intervention –

この論文をさがす

抄録

Objective: Distigmine can cause cholinergic crisis as the side effect.  In 2010, the safety information of distigmine was announced and its dosage was changed up to 5 mg per day.  However, the malpractice that a pharmacist dispensed over dose of distigmine caused severe health damages in a community pharmacy.  Therefore, we made the protocol with the urologists for the appropriate use of distigmine, including contents of monitoring the side effects.  The purpose of this study was to measure using the protocol was useful for the propulsion of proper use of distigmine.<br>Methods: The protocol was introduced in 10 community pharmacies and 1 hospital pharmacy from December 2013 to April 2014, and the patients and pharmacists were filled out the answer to the questions that we have made.  The protocol consisted of five main checks; the dosage, lower urinary tract symptom, presence of renal disease, combined drugs, and signs of the side effects.  Each patient was filled out the checklist given by the pharmacist to monitor the signs of the side effects for 2 weeks.<br>Results: The 3 prescriptions of distigmine (18.8%) were more than 10 mg per day.  Although 2 patients were confirmed diarrhea and sweating etc., they were mild.  The pharmacists significantly more (p<0.05) answered that the protocol made their motivation to do the pharmaceutical interventions.  All of the patients answered that the pharmaceutical interventions made them relieved.<br>Conclusion: The use of protocol that we made supported pharmacists to do the pharmaceutical interventions and patients welcome them.

収録刊行物

  • 医薬品情報学

    医薬品情報学 18 (2), 95-105, 2016

    一般社団法人　日本医薬品情報学会

被引用文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ